Histamine mediates osteoclastic resorption only during the acute phase of bone loss in ovariectomized rats

Experimental Physiology

Volumn 91, Issue 3, 2006, Pages 561-570

  Lesclous, Ph ^a   Schramm, F ^a   Gallina, S ^a   Baroukh, B ^a   Guez, D ^a   Saffar, J L ^a,b  

^a France   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; FAMOTIDINE; HISTAMINE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMUR; LONG BONE; LUMBAR SPINE; MALE; MAST CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; RAT; TRABECULAR BONE; UTERUS WEIGHT;

EID: 33646092305     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2006.033217     Document Type: Article

References (40)

1. Ammann P Rizzoli R Bonjour JP Bourrin S Meyer JM Vassalli P & Garcia I 1997 Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency J Clin Invest 99 1699 1703
2. Bagi CM Brommage R Deleon L Adams S Rosen D & Sommer A 1994 Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats J Bone Miner Res 9 1301 1312
3. Dvornyk V Recker RR & Deng HW 2003 Gene expression studies of osteoporosis: implications for microarray research Osteoporosis Int 14 451 461
4. 2-receptor antagonists. Standard therapy for acid-peptic diseases New Engl J Med 323 1672 1680
5. Fitzpatrick LA Buzas E Gagne TJ Nagy A Horvath C Ferencz V Mester A Kari B Ruan M Falus A & Barsony J 2003 Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss Proc Natl Acad Sci U S A 100 6027 6032
6. Harnish DC Albert LM Leathurby Y Eckert AM Ciarletta A Kasaian M & Keith JC Jr. 2004 Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol 286 G118 G125
7. Kalu DN Liu CC Hardin RR & Hollis BW 1989 The aged rat model of ovarian hormone deficiency bone loss Endocrinology 124 7 16
8. Khosla S Peterson JM Egan K Jones JD & Riggs BL 1994 Circulating cytokine levels in osteoporotic and normal women J Clin Endocrinol Metab 79 707 711
9. Kim MS Chae HJ Shin TY Kim HM & Kim HR 2001 Estrogen regulates cytokine release in human mast cells Immunopharmacol Immunotoxicol 24 495 504
10. Kimble RB Matayoshi AB Vannice JL Kung VT Williams C & Pacifici R 1995 Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period Endocrinology 136 3054 3061
11. Lesclous Ph Guez D Baroukh B Vignery A & Saffar JL 2004 Histamine participates in the early phase of trabecular bone loss in ovariectomized rats Bone 34 91 99
12. Lesclous P Guez D Llorens A & Saffar JL 2001 Time-course of mast cell accumulation in rat bone marrow after ovariectomy Calcif Tissue Int 68 297 303
13. 2 receptor antagonist cimetidine Bone 30 131 136
14. Lesclous P & Saffar JL 1999 Mast cells accumulate in rat bone marrow after ovariectomy Cells Tissues Organs 164 23 29
15. Li Y Chi L Stechschulte DJ & Dileepan KN 2001 Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha Microvasc Res 61 253 262
16. Li M Liang H Shen Y & Wronski TJ 1999 Parathyroid hormone stimulates cancellous bone formation at skeletal sites, regardless of marrow composition in ovariectomized rats Bone 24 95 100
17. Liu CC & Kalu DN 1990 Human parathyroid hormone (1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats J Bone Miner Res 5 973 982
18. Lorenzo JA Naprta A Rao Y Alander C Glaccum M Widmer M Gronowicz G Kalinowski J & Pilbeam CC 1998 Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy Endocrinology 139 3022 3025
19. McMillan PJ Dewri RA Joseph EE Schultz RJ & Deftos LJ 1989 Rapid changes of light microscopic indices of osteoclast-bone relationships correlated with electron microscopy Calcif Tissue Int 44 399 405
20. Mor S Nagler A Barak V Handel ZT Geller-Bernstein C & Fabian I 1995 Histamine enhances granulocyte-macrophage colony-stimulating factor and interleukin-6 production by human peripheral blood mononuclear cells J Leukoc Biol 58 445 450
21. Nakae S Suto H Kakurai M Sedgwick JD Tsai M & Galli SJ 2005 Mast cells enhance T cell activation: importance of mast cell-derived TNF Proc Nat Acad Sci U S A 102 6467 6472
22. Okimoto N Tsurukami H Okazaki Y Nishida S Sakai A Ohnishi H Hori M Yasukawa K & Nakamura T 1998 Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats Bone 22 523 531
23. Pacifici R Brown C Puscheck E Friedrich E Slatopolsky E Maggio D McCracken R & Avioli LV 1991 Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells Proc Natl Acad Sci U S A 88 5134 5138
24. Parfitt M Drezner MK Glorieux FH Kanis JA Malluche H Meunier PJ Ott SM & Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units J Bone Miner Res 2 595 610
25. Poli V Balena R Fattori E Markatos A Yamamoto M Tanaka H Ciliberto G Rodan GA & Costantini F 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion EMBO J 13 1189 1196
26. Sahin G Ozturk C Bagis S Cimen OB & Erdogan C 2002 Correlation of serum cytokine levels with axial bone mineral density Singapore Med J 43 576 578
27. Schneider E Ploemacher RE Nabarra B Brons NH & Dy M 1993 Mast cells and their committed precursors are not required for interleukin-3-induced histamine synthesis in murine bone marrow: characteristics of histamine-producing cells Blood 81 1161 1169
28. Schneider E Rolli-Derkinderen M Arock M & Dy M 2002 Trends in histamine research: new functions during immune responses and hematopoiesis Trends Immunol 23 255 263
29. v mast cell deficient mice Bone 12 227 236
30. Sims NA Morris HA Moore RJ & Durbridge TC 1996 Increased bone resorption precedes increased bone formation in the ovariectomized rat Calcif Tissue Int 59 121 127
31. Takamatsu S & Nakano N 1998 Regulation of interleukin-6, and macrophage colony-stimulating factor mRNA levels by histamine in stromal cell line (MC3T3-G2/PA6) Inflamm Res 47 221 226
32. 2 blockers Mol Pharmacol 43 365 371
33. Vannier E & Dinarello CA 1994 Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheal blood mononuclear cells J Biol Chem 269 9952 9956
34. Wada S Udagawa N Nagata N Martin TJ & Findlay DM 1996 Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts Endocrinology 137 1042 1048
35. Wang L Orhil PB Banu J & Kalu DN 2001 Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats Bone 28 202 207
36. Weitzmann MN & Pacifici R 2005 The role of T lymphocytes in bone metabolism Immunol Rev 208 154 168
37. Wronski TJ Cintron M & Dann LM 1988 Temporal relationship between bone loss and increased bone turnover in ovariectomized rats Calcif Tissue Int 43 179 183
38. Wronski TJ Dann LM & Horner LS 1989 Time course of vertebral osteopenia in ovariectomized rats Bone 10 295 301
39. Wronski TJ Pun S & Liang H 1999 Effects of age, estrogen depletion, and parathyroid hormone treatment on vertebral cancellous wall width in female rats Bone 25 465 468
40. 2-receptor antagonist, cimetidine, inhibits the articular osteopenia in rats with adjuvant-induced arthritis by suppressing the osteoclast differentiation induced by histamine J Pharmacol Sci 92 43 49